Before you invest in the Oura IPO, understand what you’re buying

AI Summary

MarketWatch examines what investors would be buying in a potential Oura IPO, noting that the health-data company could see its share price rise but also faces significant risks. The article focuses on the company’s business and investment outlook rather than reporting a completed offering.

The health-data company could see a pop in its stock price, but there are plenty of warning signs